KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pacific Biosciences Of California (PACB) Other Non-Current Assets (2016 - 2025)

Historic Other Non-Current Assets for Pacific Biosciences Of California (PACB) over the last 17 years, with Q3 2025 value amounting to $8.8 million.

  • Pacific Biosciences Of California's Other Non-Current Assets rose 29495.95% to $8.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.8 million, marking a year-over-year increase of 29495.95%. This contributed to the annual value of $9.3 million for FY2024, which is 2990.06% down from last year.
  • Pacific Biosciences Of California's Other Non-Current Assets amounted to $8.8 million in Q3 2025, which was up 29495.95% from $9.0 million recorded in Q2 2025.
  • Over the past 5 years, Pacific Biosciences Of California's Other Non-Current Assets peaked at $13.3 million during Q4 2023, and registered a low of $2.2 million during Q3 2024.
  • Over the past 5 years, Pacific Biosciences Of California's median Other Non-Current Assets value was $3.3 million (recorded in 2021), while the average stood at $5.2 million.
  • Data for Pacific Biosciences Of California's Other Non-Current Assets shows a peak YoY increase of 31198.01% (in 2023) and a maximum YoY decrease of 4122.58% (in 2023) over the last 5 years.
  • Over the past 5 years, Pacific Biosciences Of California's Other Non-Current Assets (Quarter) stood at $5.1 million in 2021, then plummeted by 36.72% to $3.2 million in 2022, then skyrocketed by 311.98% to $13.3 million in 2023, then decreased by 29.9% to $9.3 million in 2024, then decreased by 5.69% to $8.8 million in 2025.
  • Its Other Non-Current Assets was $8.8 million in Q3 2025, compared to $9.0 million in Q2 2025 and $9.2 million in Q1 2025.